The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2023 | Advancing colorectal cancer treatment: molecular profiling for expanded therapeutic
Olatunji Alese, MD, Emory Winship Cancer Institute, Atlanta, GA, explains how standard procedure in colorectal cancer involves determining the molecular profile of tumors, especially in advanced scenarios. The work presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL, aims to diversify and expand treatment possibilities. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
